Application
C7orf50 Antibody (N-term) western blot analysis in mouse lung tissue lysates (15ug/lane).This demonstrates the C7orf50 antibody detected C7orf50 protein (arrow).Application
C7orf50 Antibody (N-term) immunohistochemistry analysis in formalin fixed and paraffin embedded human cervix carcinoma followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the C7orf50 Antibody (N-term) for immunohistochemistry. Clinical relevance has not been evaluated.| Product Name | C7orf50 Antibody (N-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | C7orf50; Uncharacterized protein C7orf50 |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBIHC |
| WB:1:100~500 IHC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Alternative Names | C7orf50 Uncharacterized protein C7orf50 |
|---|---|
| Molecular Weight(MW) | 22083 Da |
| Tissue Specificity | This C7orf50 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 45-74 amino acids from the N-terminal region of human C7orf50. |
| Entrez Gene | 84310 |
|---|---|
| Nucleotide Accession | NP_115726.1 |
Application
C7orf50 Antibody (N-term) western blot analysis in mouse lung tissue lysates (15ug/lane).This demonstrates the C7orf50 antibody detected C7orf50 protein (arrow).
Application
C7orf50 Antibody (N-term) immunohistochemistry analysis in formalin fixed and paraffin embedded human cervix carcinoma followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the C7orf50 Antibody (N-term) for immunohistochemistry. Clinical relevance has not been evaluated.| Application Notes | WB:1:100~500 IHC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
